Healthcare: Carl Icahn Fires a Shot at Cigna and Express Scripts’ Planned Tie-Up

Here’s why activist billionaire investor Carl Icahn is telling Cigna shareholders to vote against its purchase of Express Scripts. Also, what Regeneron Pharmaceuticals and bluebird bio's new deal means for investors.